BIOMAT Database Logo BIOMAT Database Logo

Endocrine function of the canine pancreas. The effect of duct ligation and transplantation of the total duct ligated pancreas. 1975

L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken

Pancreas transplantation was studied in the dog using a total duct ligated pancreas as allograft. In a group of 10 mongrel dogs the effects of long-term (6-36 months) total duct ligation on the endocrine pancreas function were studied by means of repeated intravenous glucose tolerance tests (iv-GTT). One year after total duct ligation the mean glucose assimilation coefficient (k-value) was 75%, the median insulin peak value (IPV) 63% and "total" insulin secretion in the first thirty minutes (TIS) 58% of the pre-operative values. These levels were maintained up to three years after duct ligation. The total duct ligated pancreas was then used as an allograft in 28 beagles in order to study the influence of DL-A (dog leucocyte-antigens) matching on the survival time of the graft. DL-A identity compared to one or two haplotype difference gave a fourfold increase in median survival time from 9 to 40 days. In a second group of 14 beagles with one haplotype difference the effect of immunosuppressive therapy was studied. The methods used (antilymphocyte serum and a combination of prednisone and azathioprine) increased the median survival time to the level seen in DL-A identity. In conclusion the total duct ligated pancreas can be used as an insulin secreting allograft, providing rejection can be suppressed adequately.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014022 Tissue Survival The span of viability of a tissue or an organ. Organ Survival,Organ Viability,Tissue Viability,Survival, Organ,Survival, Tissue,Viability, Organ,Viability, Tissue
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken
Long-term endocrine function of duct-ligated pancreas isotransplants in rats.
January 1980, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken
Pancreatic duct ligation and long-term endocrine function of pancreas transplants.
January 1973, Surgical forum,
L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken
The effect of duct obliteration on the histology and endocrine function of the canine pancreas.
July 1984, Transplantation,
L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken
Function of the duct-ligated canine pancreatic allograft.
January 1975, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken
STUDIES OF ENDOCRINE FUNCTION FOLLOWING TRANSPLANTATION OF THE CANINE PANCREAS.
November 1964, Annals of the New York Academy of Sciences,
L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken
Twenty-four-hour hypothermic preservation perfusion and storage of the duct-ligated canine pancreas with transplantation.
September 1974, Transplantation proceedings,
L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken
Behaviour of the duct-ligated canine pancreas during hypothermic albumin perfusion.
January 1975, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken
Clinical experience in transplantation of the duct-ligated pancreas segment.
December 1980, Transplantation proceedings,
L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken
Long-term function of duct-ligated and free-duct whole pancreas transplants.
October 1983, The Journal of surgical research,
L Verschoor, and H A Hulsmans, and J de Gruyl, and D L Westbroek, and I MacDicken
Pancreas transplantation in streptozotocin-diabetic juvenile pigs. Evaluation of function among duct-ligated, duct-occluded, and nonligated allografts.
December 1983, Transplantation,
Copied contents to your clipboard!